Atterocor is an innovative company focused on the accelerated development of a treatment for adrenal cancer. Founded in 2012 and backed by top-tier life sciences investors, Atterocor is based in Ann Arbor, Michigan.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 08/01/12 | Series A | 16M | Unknown |